Oxygenta Pharmaceutical Ltd.
Snapshot View

28.90 +0.95 ▲3.4%

07 October 2022, 04:01:00 PM
Volume: 718

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ssorganics.co.in
Market Cap 41.04 Cr.
Enterprise Value(EV) 92.08 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -1.96 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-06
Industry PE 31.91 Trailing Twelve Months Ending 2022-06
Book Value / Share -25.58 Trailing Twelve Months Ending 2022-06
Price to Book Value -1.13 Calculated using Price: 28.90
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.42 Cr. 14,201,300 Shares
FaceValue 10
Company Profile
SS Organics was incorporated in 1990, is a pharmaceutical company involved in the manufacture and marketing of bulk drugs and intermediates.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+3.40%
1 Week
+3.40%
1 Month
+1.40%
3 Month
+5.28%
6 Month
+16.30%
1 Year
-12.42%
2 Year
+295.89%
5 Year
+131.20%
10 Year
+301.39%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%)
Return on Capital Employed (%) -80.52 -183.16
Return on Assets (%) -10.98 -24.53 -33.71 -29.05 -29.92 -25.13 -17.07 -29.10 11.16

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds -5 -9 -16 -22 -27 -32 -35 -41 -38 -35
Non Curr. Liab. 11 15 18 21 31 31 40 44 54 59
Curr. Liab. 11 12 16 21 16 18 17 16 18 7
Minority Int.
Equity & Liab. 17 18 18 20 19 17 21 19 34 31
Non Curr. Assets 15 17 13 14 13 13 12 12 18 22
Curr. Assets 1 2 5 5 6 4 9 7 16 9
Misc. Exp. not W/O
Total Assets 17 18 18 20 19 17 21 19 34 31

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 2 6 12 8 13 21 14 52 47
Other Income 0 0 1 1 0 0 0
Total Income 3 6 12 9 14 21 14 52 47
Total Expenditure -2 -6 -10 -17 -13 -17 -23 -22 -48 -48
PBIDT -2 -3 -4 -4 -4 -3 -2 -8 4 -1
Interest 0 0 -1 -1 -1 -1 -1 -2 -1
Depreciation -1 -3 -1 -1 -1 -1 -1 -1 -2
Taxation 0 1 0 0 0 0 0 0
Exceptional Items 4 2 0
PAT -2 -4 -6 -6 -6 -5 -3 -6 3 -3
Adjusted EPS -2 -4 -6 -5 -6 -4 -3 -6 3 -2

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 -1 -3 -4 1 1 1 -8 -3 -2
Cash Fr. Inv. -3 -2 1 -2 -1 0 -1 -1 -7
Cash Fr. Finan. 0 4 4 3 1 0 -1 8 3 9
Net Change 1 -1 0 0 0 0 0 0 0
Cash & Cash Eqvt 1 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 17.17 17.17 17.17 17.17 17.17 12.33 12.33 12.33 12.33
Public 82.83 82.83 82.83 82.83 82.83 87.67 87.67 87.67 87.67
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 30 Sep 2022
Closure of Trading Window
Pursuant to the Companys Code for Prevention of Insider Trading the trading window for dealing in the Companys Securities will remain closed from Saturday October 01st 2022.The Closure is in connection with the finalization of financial statements/ results for the quarter and half year ending September 30 2022.The trading window will open 48 hours after the said financial results are declared to the Stock Exchanges. This is for your information and records.
Wed, 28 Sep 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
With reference to the subject cited we are pleased to inform you that the 29th Annual General Meeting (AGM) of the Shareholders of the Company was held on 29th day of September 2022 at 03.00 P.M. through Video Conferencing! Other Audio-Visual Means (VC/OAVM).Please find the attached Voting Results of the 29th Annual General Meeting of the shareholders of the Company along with the Scrutinizers Report.
Tue, 27 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
With reference to the subject cited we are pleased to inform you that the 29thAnnual General Meeting (AGM) of the Shareholders of the Company was held on 26th day of September 2022 at 03.00 P.M. through Video Conferencing/ Other Audio-Visual Means (VC/OAVM).Please find the attached Proceedings of the 29th Annual General Meeting of the Shareholders of the Company.Please take the same on record.

Technical Scans View Details >>

Fri, 07 Oct 2022
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High
High Increase 2 Years High Increase 2 Years
High Increase 5 Years High Increase 5 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,656.62 953.00 -0.1%
Divi's Laboratories Ltd. 99,250.74 3,738.70 +0.0%
Cipla Ltd. 91,332.41 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. 72,821.94 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. 63,207.02 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. 53,000.56 1,566.00 -2.3%
Zydus Lifesciences Ltd. 42,689.71 421.75 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.79 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.96 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 36.70 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.35 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.55 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.17 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.66 421.75 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.56 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 4.25 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.60 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.64 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.29 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.54 421.75 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 421.75 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 421.75 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 421.75 -0.3%

FAQ's On Oxygenta Pharmaceutical Ltd.

What is Oxygenta Pharma share price?

Can I buy Oxygenta Pharma shares now?

What is the Market Cap of Oxygenta Pharma?

What is the 52 Week High and Low of Oxygenta Pharma?

What is the trend of Oxygenta Pharma share price?